Novai. a medtech company combatting blindness and disability by pioneering early detection and intervention for eye and brain diseases, today announced the publication of a peer-reviewed study in Expert Review of Ophthalmology, which successfully demonstrates its ‘Detection of Apoptosing Retinal Cells’ (DARC) imaging technology as a promising biomarker for identifying patients at high risk of central vision loss caused by macular atrophy (MA).